Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom

International Journal of Women's Health

Volumn 5, Issue 1, 2013, Pages 261-269

  DiBonaventura, Marco daCosta ^a   Chandran, Arthi ^b   Hsu, Ming Ann ^b   Bushmakin, Andrew ^b  

^a KANTAR HEALTH   (United States)

^b PFIZER INC   (United States)

Author keywords

Health status; Menopause; Vasomotor symptoms; Work productivity

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECONOMIC EVALUATION; FEMALE; FRANCE; GERMANY; HEALTH STATUS; HUMAN; ITALY; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; POSTMENOPAUSE; PREDICTION; PREVALENCE; PRODUCTIVITY; SCORING SYSTEM; SPAIN; SYNDROME DELINEATION; UNITED KINGDOM; VASOMOTOR DISORDER;

EID: 84878405105     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S39027     Document Type: Article

References (25)

1. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health. 1985;8(3):261-268.
2. Freeman EW, Sammel MD, Lin H, Garcia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause. 2005;12(3):258-266.
3. [No authors listed]. NIH State-of-the-Science conference statement on management of menopause-related symptoms. NIH Consens State Sci Statements. 2005;22(1):1-38.
4. Genazzani AR, Schneider HPG, Panay N, Nijland EA. The European Menopause Survey 2005: women's perceptions on menopause and postmenopause hormone therapy. Gynecol Endocrinol. 2006;22(7):369-375.
5. North American Menopause Society. Menopause Practice: A Clinician's Guide, 4th ed. Mayfield Heights, OH: North American Menopause Society; 2010.
6. Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by women in midlife: menopausal transition or aging? Menopause. 2009;16(5): 1021-1029.
7. Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas. 2007;58(4):348-358.
8. Karaçam Z, Seker SE. Factors associated with menopausal symptoms and their relationship with the quality of life among Turkish women. Maturitas. 2007;58(1):75-82.
9. Avis NE, Ory M, Matthews KA, Schocken M, Bromberger J, Colvin A. Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN). Med Care. 2003;41(11):1262-1276.
10. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation (SWAN). Menopause. 2009;16(5):860-869.
11. Cantril H. The Pattern of Human Concerns. New Brunswick, NJ: Rutgers University Press; 1965.
12. Gallicchio L, Miller S, Zacur H, Flaws JA. Race and health-related quality of life in midlife women in Baltimore, Maryland. Maturitas. 2009;63(1):67-72.
13. Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas. 2009;62(2): 153-159.
14. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ. 1993;307(6908):836-840.
15. Hess R, Chang C-C, Ness RB, Hays RD, Kapoor WN, Bryce CL. The associations of menopause and health-related quality of life with health services utilization: results from the STRIDE study. Abstract presented at the 32nd Annual Meeting of the Society of Medical Decision Making, Toronto, Ontario, Canada, October 24-27, 2010.
16. DiBonaventura MD, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ. 2010;13(4):709-718.
17. Langley P, Muller-Schwerfe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ. 2010;13(4): 662-672.
18. Liu GG, DiBonaventura MD, Yuan Y, et al. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health. 2012;15(Suppl 1):S65-S72.
19. Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med. 2011;53(9):1025-1029.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
21. Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG. Evaluation of the Menopause Rating Scale. Zentralbl Gynakol. 1994;116(1):16-23. German.
22. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337-343.
23. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4.
24. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365.
25. Kontodimopoulos N, Pappa E, Papadopoulos AA, Tountas Y, Niakas D. Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual Life Res. 2009;18(1):87-97.